Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| New Zealand | 15 | 2021 | 2073 | 1.37 | Why? |
| Neisseria gonorrhoeae | 2 | 2018 | 142 | 1.29 | Why? |
| Rotavirus Vaccines | 2 | 2018 | 203 | 1.19 | Why? |
| Rotavirus Infections | 2 | 2018 | 355 | 1.06 | Why? |
| Trichomonas vaginalis | 2 | 2018 | 19 | 0.93 | Why? |
| Mycoplasma genitalium | 1 | 2018 | 30 | 0.74 | Why? |
| Rotavirus | 2 | 2018 | 329 | 0.72 | Why? |
| Chlamydia trachomatis | 1 | 2018 | 172 | 0.66 | Why? |
| International Normalized Ratio | 1 | 2018 | 300 | 0.64 | Why? |
| Microbiological Techniques | 1 | 2018 | 232 | 0.59 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.54 | Why? |
| Virology | 1 | 2018 | 489 | 0.54 | Why? |
| Gastroenteritis | 1 | 2018 | 489 | 0.49 | Why? |
| Sexually Transmitted Diseases | 1 | 2018 | 694 | 0.41 | Why? |
| Trichomonas Vaginitis | 2 | 2018 | 7 | 0.37 | Why? |
| Drug Resistance, Bacterial | 1 | 2018 | 1414 | 0.36 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.33 | Why? |
| Feces | 2 | 2018 | 4235 | 0.32 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.30 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.27 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.22 | Why? |
| Comparative Effectiveness Research | 1 | 2020 | 178 | 0.20 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.20 | Why? |
| Mycoplasma Infections | 1 | 2018 | 65 | 0.18 | Why? |
| Kinetoplastida | 1 | 2017 | 1 | 0.17 | Why? |
| Campylobacter | 1 | 2017 | 34 | 0.17 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.17 | Why? |
| Salmonella | 1 | 2017 | 58 | 0.17 | Why? |
| Insecta | 1 | 2017 | 122 | 0.16 | Why? |
| Clinical Audit | 1 | 2017 | 204 | 0.16 | Why? |
| Medical Overuse | 1 | 2018 | 146 | 0.16 | Why? |
| Immunoenzyme Techniques | 1 | 2018 | 448 | 0.16 | Why? |
| Chlamydia Infections | 1 | 2018 | 248 | 0.15 | Why? |
| Insect Vectors | 1 | 2017 | 227 | 0.14 | Why? |
| Gonorrhea | 1 | 2018 | 315 | 0.13 | Why? |
| RNA, Viral | 1 | 2020 | 32276 | 0.12 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.12 | Why? |
| False Positive Reactions | 1 | 2018 | 1338 | 0.12 | Why? |
| Interprofessional Relations | 1 | 2020 | 1013 | 0.12 | Why? |
| Vaccines, Attenuated | 1 | 2018 | 952 | 0.12 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.12 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.12 | Why? |
| Drug Monitoring | 1 | 2018 | 1408 | 0.10 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2021 | 11367 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Microbial Sensitivity Tests | 1 | 2018 | 2886 | 0.10 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.09 | Why? |
| Humans | 16 | 2021 | 930598 | 0.08 | Why? |
| Serologic Tests | 1 | 2021 | 4359 | 0.08 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.08 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.08 | Why? |
| Hospitalization | 1 | 2018 | 54280 | 0.08 | Why? |
| Politics | 1 | 2020 | 1824 | 0.08 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.08 | Why? |
| Leadership | 1 | 2020 | 2241 | 0.08 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.08 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.08 | Why? |
| Specimen Handling | 2 | 2020 | 6190 | 0.07 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2020 | 11304 | 0.07 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.07 | Why? |
| Infant | 2 | 2018 | 30274 | 0.07 | Why? |
| Child | 5 | 2021 | 70012 | 0.07 | Why? |
| Male | 10 | 2021 | 367725 | 0.07 | Why? |
| Female | 10 | 2021 | 380317 | 0.07 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.07 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.06 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2017 | 3388 | 0.06 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| Aged | 5 | 2021 | 215776 | 0.05 | Why? |
| Adult | 6 | 2021 | 244371 | 0.05 | Why? |
| Leishmania | 1 | 2017 | 28 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.04 | Why? |
| False Negative Reactions | 1 | 2020 | 1785 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| Costs and Cost Analysis | 1 | 2017 | 694 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.02 | Why? |
| Civil Defense | 1 | 2020 | 1687 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Australia | 1 | 2017 | 6306 | 0.02 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.01 | Why? |
| Communication | 1 | 2020 | 5206 | 0.01 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.01 | Why? |
| Phylogeny | 1 | 2017 | 13341 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
McAuliffe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(105)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_